XTX Topco’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
284,357
+263,147
| +1,241% | +$1.4M | 0.06% | 451 |
|
|
2025
Q1 | $188K | Sell |
21,210
-42,870
| -67% | -$380K | 0.01% | 1717 |
|
|
2024
Q4 | $879K | Buy |
64,080
+52,923
| +474% | +$726K | 0.07% | 367 |
|
|
2024
Q3 | $306K | Sell |
11,157
-1,370
| -11% | -$37.5K | 0.02% | 1164 |
|
|
2024
Q2 | $306K | Buy |
+12,527
| New | +$306K | 0.03% | 948 |
|
|
2023
Q3 | – | Sell |
-9,825
| Closed | -$228K | – | 1850 |
|
|
2023
Q2 | $228K | Buy |
+9,825
| New | +$228K | 0.04% | 924 |
|
|
2021
Q2 | – | Sell |
-9,974
| Closed | -$304K | – | 995 |
|
|
2021
Q1 | $304K | Buy |
+9,974
| New | +$304K | 0.15% | 267 |
|